ArticleInternational journal of clinical and experimental medicine2015
Screening feature genes of osteosarcoma with DNA microarray: a bioinformatic analysis.
Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration.Genes & diseases · 2024Article
- Article
- Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma.Medical science monitor : international medical journal of experimental and clinical research · 2019Article
- Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples.Experimental biology and medicine (Maywood, N.J.) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To screen differentially expressed genes (DEGs) of Osteosarcoma (OS) by using the microarray expression profiles of tissues of normal person and patients with OS for early diagnosis and effective treatment of OS. We downloaded the gene expression profile of GES16088 from Gene Expression Omnibus database, including twenty samples from fourteen patients diagnosed with osteosarcoma and six normal samples as control groups. We identified the DEGs by Affy package in R language. Bioinformatic methods were used for further analysis of the screened DEGs. Firstly, cluster analysis was performed on the selected DEGs for comparison of the expression degree. After protein-protein interaction (PPI) network of differentially expressed genes was constructed by STRING, we analyzed gene functions with DAVID and WebGestalt. Compared with the control, we screened three distinctly up-regulated genes. These DEGs had close relationship with transmission signaling pathway, organ and system development. The up-regulated gene COL was the most representative genes among the DEGs. The screened DEGs have a great significance on studying mechanism of osteosarcoma. It might distinguish normal and pathological tissues of OS and thus become target genes for monitoring, diagnosis and treatment of the OS. It has the potential to use in clinic.
Indexed as
Identifiers
26221251PMC4509196What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.